Gabelli Healthcare & Wellnessrx Trust Form 4 insider transactions

NYSE
Saba Capital Management, along with Boaz Weinstein, reports increased beneficial ownership of Gabelli Healthcare & WellnessRx Trust (GRX) common stock through recent purchases.
NYSE
Saba Capital Management, L.P. reports acquiring additional shares of Gabelli Healthcare & WellnessRx Trust, increasing its beneficial ownership.
NYSE
Saba Capital Management, along with Boaz Weinstein, reports increased beneficial ownership of Gabelli Healthcare & WellnessRx Trust shares through recent purchases.
NYSE
Mario Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, reports purchasing 1,000 common shares at $10.202 per share.
NYSE
Saba Capital Management, L.P. reports acquiring 1,500 shares of Gabelli Healthcare & WellnessRx Trust, increasing its indirect holdings.
NYSE
Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, reported the purchase of 1,000 common shares and indirect ownership of additional shares through various entities.
NYSE
Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, purchased 4,000 common shares at $9.8 each on January 16, 2025.
NYSE
Saba Capital Management, L.P. has increased its holdings in Gabelli Healthcare & WellnessRx Trust by purchasing 14,833 shares of common stock.
NYSE
Director Anthonie C. van Ekris sold 1,115 shares of Gabelli Healthcare & WellnessRx Trust at a price of $9.65 per share on January 8, 2025.
NYSE
Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, has increased his holdings through direct and indirect purchases of common shares.
NYSE
Saba Capital Management, L.P. has increased its holdings in Gabelli Healthcare & WellnessRx Trust by purchasing 20,408 shares of common stock.
NYSE
Mario J. Gabelli, a director of Gabelli Healthcare & WellnessRx Trust, has increased his holdings through open market purchases of common shares.
NYSE
Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, has acquired additional shares through various entities.
NYSE
Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, reported the acquisition of 7,863 common shares on December 3, 2024.
NYSE
Saba Capital Management, along with Boaz Weinstein, reported the acquisition of 1,312 common stock shares in Gabelli Healthcare & WellnessRx Trust on December 2, 2024, increasing their total holdings.
NYSE
Saba Capital Management, L.P. has increased its holdings in Gabelli Healthcare & WellnessRx Trust by purchasing 5,153 shares of common stock at $10.4 per share.
NYSE
Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, purchased 112 common shares at $10.305 per share.
NYSE
Saba Capital Management, along with Boaz Weinstein, reported acquiring additional shares of Gabelli Healthcare & WellnessRx Trust, increasing their indirect holdings.
NYSE
Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, has increased his indirect holdings by purchasing 3,000 common shares.
NYSE
Saba Capital Management, L.P. has increased its holdings in Gabelli Healthcare & WellnessRx Trust by purchasing 4,341 shares of common stock.
NYSE
Saba Capital Management, L.P. has increased its holdings in Gabelli Healthcare & WellnessRx Trust by purchasing 4,876 shares of common stock.
NYSE
Mario J. Gabelli, a director and control person of the adviser, has acquired 4,000 common shares of Gabelli Healthcare & WellnessRx Trust at a price of $10.14 per share.
NYSE
Saba Capital Management, L.P. reports purchasing 5,364 shares of Gabelli Healthcare & WellnessRx Trust (GRX) at $10.36 per share, increasing its indirect holdings.
NYSE
Saba Capital Management, a 10% owner and director in Gabelli Healthcare & WellnessRx Trust, reports purchasing additional shares of common stock.
NYSE
Saba Capital Management, L.P. reports acquiring additional shares of Gabelli Healthcare & WellnessRx Trust, increasing its beneficial ownership.
NYSE
Saba Capital Management, L.P. reports increased ownership in Gabelli Healthcare & WellnessRx Trust (GRX) through recent common stock purchases.
NYSE
Saba Capital Management, L.P. reports increased ownership in Gabelli Healthcare & WellnessRx Trust (GRX) through recent common stock purchases.
NYSE
Saba Capital Management, L.P. reports acquiring additional shares of Gabelli Healthcare & WellnessRx Trust, increasing its beneficial ownership.
NYSE
Mario Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, reports purchasing 5,000 common shares at $10.7561 on August 19, 2024.
NYSE
Saba Capital Management, L.P. has increased its beneficial ownership in Gabelli Healthcare & WellnessRx Trust (GRX) through recent purchases of common stock.